British Journal of Cancer - Table of Contents alert Volume 111 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 111, Issue 6 (1021-1248) Published online 9 September 2014 In this issue Guideline Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Don't miss out! Discover which British Journal of Cancer articles your colleagues are reading — view the top ten now.  Top Ten Articles   Guideline Top Guidelines for the use of cell lines in biomedical research R J Geraghty, A Capes-Davis, J M Davis, J Downward, R I Freshney, I Knezevic, R Lovell-Badge, J R W Masters, J Meredith, G N Stacey, P Thraves and M Vias Br J Cancer 2014 111: 1021-1046; advance online publication, August 12, 2014; 10.1038/bjc.2014.166 Abstract | Full Text Minireviews Top Sunitinib re-challenge in advanced renal-cell carcinoma C Porta, C Paglino and V Grünwald Br J Cancer 2014 111: 1047-1053; advance online publication, May 6, 2014; 10.1038/bjc.2014.214 Abstract | Full Text Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells S Takeishi and K I Nakayama Br J Cancer 2014 111: 1054-1059; advance online publication, May 22, 2014; 10.1038/bjc.2014.259 Abstract | Full Text Clinical Studies Top Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study) M Quintela-Fandino, A Urruticoechea, J Guerra, M Gil, A Gonzalez-Martin, R Marquez, E Hernandez-Agudo, C Rodriguez-Martin, M Gil-Martin, R Bratos, M J Escudero, S Vlassak, F Hilberg and R Colomer Br J Cancer 2014 111: 1060-1064; advance online publication, July 24, 2014; 10.1038/bjc.2014.397 Abstract | Full Text EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial H Cheng, K Ballman, M Vassilakopoulou, A C Dueck, M M Reinholz, K Tenner, J Gralow, C Hudis, N E Davidson, G Fountzilas, A E McCullough, B Chen, A Psyrri, D L Rimm and E A Perez Br J Cancer 2014 111: 1065-1071; advance online publication, August 12, 2014; 10.1038/bjc.2014.442 Abstract | Full Text A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma C Y Cheah, K E Herbert, K O'Rourke, G A Kennedy, A George, P L Fedele, M Gilbertson, S Y Tan, D S Ritchie, S S Opat, H M Prince, M Dickinson, K Burbury, M Wolf, E H Januszewicz, C S Tam, D A Westerman, D A Carney, S J Harrison and J F Seymour Br J Cancer 2014 111: 1072-1079; advance online publication, July 29, 2014; 10.1038/bjc.2014.405 Abstract | Full Text HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients X-Y Zhao, Y-J Chang, L-P Xu, X-H Zhang, K-Y Liu, D Li and X-J Huang Br J Cancer 2014 111: 1080-1088; advance online publication, July 31, 2014; 10.1038/bjc.2014.423 Abstract | Full Text Intraarterial chemotherapy as the first-line therapy in penile cancer P-H Chiang, C-H Chen and Y-C Shen Br J Cancer 2014 111: 1089-1094; advance online publication, July 24, 2014; 10.1038/bjc.2014.394 Abstract | Full Text DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women A Boers, R P Bosgraaf, R W van Leeuwen, E Schuuring, D A M Heideman, L F A G Massuger, V M J Verhoef, J Bulten, W J G Melchers, A G J van der Zee, R L M Bekkers and G B A Wisman Br J Cancer 2014 111: 1095-1101; advance online publication, July 17, 2014; 10.1038/bjc.2014.392 Abstract | Full Text The impact of plasma epstein–barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study L-Q Tang, Q-Y Chen, S-S Guo, W-H Chen, C-F Li, L Zhang, X-P Lai, Y He, Y-X-X Xu, D-P Hu, S-H Wen, Y-T Peng, H Liu, L-T Liu, S-M Yan, L Guo, C Zhao, K-J Cao, Q Liu, C-N Qian, J Ma, X Guo, M-S Zeng and H-Q Mai Br J Cancer 2014 111: 1102-1111; advance online publication, July 22, 2014; 10.1038/bjc.2014.393 Abstract | Full Text Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review D A M Sloothaak, B Mirck, C J A Punt, W A Bemelman, J D W van der Bilt, A D’Hoore and P J Tanis Br J Cancer 2014 111: 1112-1121; advance online publication, July 15, 2014; 10.1038/bjc.2014.369 Abstract | Full Text The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials E Segelov, D Chan, J Shapiro, T J Price, C S Karapetis, N C Tebbutt and N Pavlakis Br J Cancer 2014 111: 1122-1131; advance online publication, July 29, 2014; 10.1038/bjc.2014.404 Abstract | Full Text Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch, D Hedley, M J Moore, E Friedman and S Gallinger Br J Cancer 2014 111: 1132-1138; advance online publication, July 29, 2014; 10.1038/bjc.2014.418 Abstract | Full Text Translational Therapeutics Top Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation J J Souchek, M J Baine, C Lin, S Rachagani, S Gupta, S Kaur, K Lester, D Zheng, S Chen, L Smith, A Lazenby, S L Johansson, M Jain and S K Batra Br J Cancer 2014 111: 1139-1149; advance online publication, July 15, 2014; 10.1038/bjc.2014.385 Abstract | Full Text Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines L Sawers, M J Ferguson, B R Ihrig, H C Young, P Chakravarty, C R Wolf and G Smith Br J Cancer 2014 111: 1150-1158; advance online publication, July 10, 2014; 10.1038/bjc.2014.386 Abstract | Full Text Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts M Chiu, S Tardito, S Pillozzi, A Arcangeli, A Armento, J Uggeri, G Missale, M G Bianchi, A Barilli, V Dall'Asta, N Campanini, E M Silini, J Fuchs, S Armeanu-Ebinger and O Bussolati Br J Cancer 2014 111: 1159-1167; advance online publication, July 29, 2014; 10.1038/bjc.2014.425 Abstract | Full Text Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells C D’Amato, R Rosa, R Marciano, V D’Amato, L Formisano, L Nappi, L Raimondo, C Di Mauro, A Servetto, F Fulciniti, A Cipolletta, C Bianco, F Ciardiello, B M Veneziani, S De Placido and R Bianco Br J Cancer 2014 111: 1168-1179; advance online publication, August 5, 2014; 10.1038/bjc.2014.421 Abstract | Full Text The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer T Hemdan, M Lindén, S B Lind, A V Namuduri, E Sjöstedt, T D de Ståhl, A Asplund, P-U Malmström and U Segersten Br J Cancer 2014 111: 1180-1187; advance online publication, July 29, 2014; 10.1038/bjc.2014.427 Abstract | Full Text Molecular Diagnostics Top Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1) W Li, M Liu, Y Feng, Y-F Xu, Y-F Huang, J-P Che, G-C Wang, X-D Yao and J-H Zheng Br J Cancer 2014 111: 1188-1200; advance online publication, July 10, 2014; 10.1038/bjc.2014.382 Abstract | Full Text Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error M Shipitsin, C Small, S Choudhury, E Giladi, S Friedlander, J Nardone, S Hussain, A D Hurley, C Ernst, Y E Huang, H Chang, T P Nifong, D L Rimm, J Dunyak, M Loda, D M Berman and P Blume-Jensen Br J Cancer 2014 111: 1201-1212; advance online publication, July 17, 2014; 10.1038/bjc.2014.396 Abstract | Full Text Unique volatolomic signatures of TP53 and KRAS in lung cells M P A Davies, O Barash, R Jeries, N Peled, M Ilouze, R Hyde, M W Marcus, J K Field and H Haick Br J Cancer 2014 111: 1213-1221; advance online publication, July 22, 2014; 10.1038/bjc.2014.411 Abstract | Full Text Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role A Warth, J Cortis, A Soltermann, M Meister, J Budczies, A Stenzinger, B Goeppert, M Thomas, F J F Herth, P Schirmacher, P A Schnabel, H Hoffmann, H Dienemann, T Muley and W Weichert Br J Cancer 2014 111: 1222-1229; advance online publication, July 22, 2014; 10.1038/bjc.2014.402 Abstract | Full Text Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion Y Hassona, N Cirillo, K Heesom, E K Parkinson and S S Prime Br J Cancer 2014 111: 1230-1237; advance online publication, August 12, 2014; 10.1038/bjc.2014.438 Abstract | Full Text Genetics and Genomics Top The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer M R Akbari, C J D Wallis, A Toi, J Trachtenberg, P Sun, S A Narod and R K Nam Br J Cancer 2014 111: 1238-1240; advance online publication, August 7, 2014; 10.1038/bjc.2014.428 Abstract | Full Text Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100 B P Schneider, L Li, F Shen, K D Miller, M Radovich, A O'Neill, R J Gray, D Lane, D A Flockhart, G Jiang, Z Wang, D Lai, D Koller, J H Pratt, C T Dang, D Northfelt, E A Perez, T Shenkier, M Cobleigh, M L Smith, E Railey, A Partridge, J Gralow, J Sparano, N E Davidson, T Foroud and G W Sledge Br J Cancer 2014 111: 1241-1248; advance online publication, August 12, 2014; 10.1038/bjc.2014.430 Abstract | Full Text Advertisement British Journal of Cancer has you covered. The British Journal of Cancer publishes significant research that increases the understanding of the causes of cancer; informs about timely detection and accurate diagnosis; helps develop personalised therapy; and drives improvements in the treatment and survival of patients.  Subscribe today and don't miss a beat.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.